Hypothalamic Extended Synaptotagmin-3 Contributes to the Development of Dietary Obesity and Related Metabolic Disorders

Yi Zhang,Yunliang Guan,Susu Pan,Lihong Yan,Ping Wang,Zhuo Chen,Qing Shen,Faming Zhao,Xin Zhang,Juan Li,Juxue Li,Dongsheng Cai,Guo Zhang
DOI: https://doi.org/10.1073/pnas.2004392117
IF: 11.1
2020-01-01
Proceedings of the National Academy of Sciences
Abstract:Significance The epidemic of obesity has reached an alarming level worldwide. Understanding the etiology of obesity is important for identifying a new approach of prevention or treatment. Accumulating evidence demonstrates that the central nervous system plays a critical role in animal’s energy homeostasis. Here, we show that extended synaptotagmin (E-Syt3) is expressed in the hypothalamus and contributes to diet-induced obesity development. Whole-body or proopiomelanocortin neuron-specific deletion of E-Syt3 significantly protects mice against DIO and related metabolic disorders. Mechanistically, we show that inhibition of E-Syt3 can lead to increased hypothalamic content of α-melanocyte-stimulating hormone. Thus, our current work suggests that E-Syt3 might be a relevant target for treating obesity.
What problem does this paper attempt to address?